The Intellectual Property Owners Association (IPO) will offer two one-hour webinars on double patenting. The first webinar, entitled "Double-Patenting: Impact of Gilead on Bio and Pharma," is being offered on January 7, 2016 from 2:00 to 3:00 pm (ET). Tim Babcock of Akros Pharma Inc., Jack Brennan of Fish & Richardson, and Jeremy Lowe of Axinn Veltrop will focus on tips for patent prosecution after Gilead v. Natco, as well as the litigation outlook with a particular focus on biosimilars. The second webinar, entitled "Double-Patenting: Tech Patents, Double Patenting, and Ex Parte Reexam," is being offered on January 8, 2016 from 2:00 to 3:00 pm (ET). Barry Bretschneider of BakerHostetler, Jeffrey Hohenshell of Medtronic, and Lissi Mojica of Dentons US LLP will examine how double patenting arises in tech company patent portfolios, how ex parte reexamination differs from other post-grant proceedings vis-a-vis double patenting, and how it can be used to invalidate vulnerable patents.
The registration fee for each webinar is $135 (government and academic rates are available upon request). Those interested in registering for the webinar can do so here.